# SeQuent Research Limited – FDA Inspection, Oct 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/sequent-research-limited/06a7d248-f057-4315-a90a-4bf4e35ca2ae
Source feed: FDA_Inspections

> FDA inspection 1068495 of SeQuent Research Limited, October 12, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1068495
- Company Name: SeQuent Research Limited
- Inspection Date: 2018-10-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Documents

- [FDA Inspection 1286970 - 2025-09-03](https://www.keypedia.com/records/fda_inspections/sequent-research-limited/7cdcd07f-31fc-4dbc-a27f-178236f2e560)
- FDA Inspection 1121166 - 2020-02-14

## Related Officers

- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)

Company: https://www.keypedia.com/companies/sequent-research-limited/ae5e367b-3cbe-428f-b4c5-02ab7b85c6b5

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8